Cargando…
Full antagonist of the IL-7 receptor suppresses chronic inflammation in non-human primate models by controlling antigen-specific memory T cells
Targeting the expansion of pathogenic memory immune cells is a promising therapeutic strategy to prevent chronic autoimmune attacks. Interleukin 7 (IL-7) is a limiting and potent cytokine produced by epithelial and stromal cells sustaining T-lymphocytes development, homeostasis and cell metabolism....
Autores principales: | Belarif, Lyssia, Vanhove, Bernard, Poirier, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551675/ https://www.ncbi.nlm.nih.gov/pubmed/31225460 http://dx.doi.org/10.15698/cst2018.12.168 |
Ejemplares similares
-
IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates
por: Belarif, Lyssia, et al.
Publicado: (2018) -
Could TNF-antagonists be a novel treatment strategy for BPH patients?
por: Vickman, Renee E., et al.
Publicado: (2022) -
To promote or inhibit glioma progression, that is the question for IL-33
por: Robbins, Stephen M., et al.
Publicado: (2020) -
Tissue-resident memory T cells orchestrate tumour-immune equilibrium
por: Park, Simone L., et al.
Publicado: (2019) -
Silence, activate, poise and switch! Mechanisms of antigenic variation in Plasmodium falciparum
por: Guizetti, Julien, et al.
Publicado: (2013)